Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | SMMT | CTLT | ||
| Company | Neurocrine Bioscienc | Summit Therapeu ADR | Catalent Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 123.27 | 18.74 | 59.09 | ||
| High | 125.14 | 18.87 | 59.84 | ||
| Low | 122.37 | 18.03 | 58.92 | ||
| Last | 124.96 | 18.50 | 59.81 | ||
| Change | +1.67 | -0.12 | +0.81 | ||
| % Change | +1.35% | -0.64% | +1.37% | ||
| Volume | 486,614 | 770,196 | 360,302 | ||
| 20-Day Average Volume | 1,087,163 | 2,045,256 | 1,708,039 | ||
| Previous Close | 123.29 | 18.62 | 59.00 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 121.87 | 20.06 | 59.08 | ||
| 20-Day Raw Stochastic | 64.40% | 11.29% | 78.59% | ||
| 20-Day Relative Strength | 55.00% | 46.47% | 53.38% | ||
| Weighted Alpha | +3.28 | +63.59 | +38.72 | ||
| Today's Opinion | 40% Sell | 40% Buy | 56% Buy | ||
| Previous Opinion | 40% Sell | 40% Buy | 8% Buy | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.79% since 11/14/24 | -4.47% since 11/14/24 | +1.51% since 11/14/24 | ||
| Low | 115.27 on 11/19/24 | 18.03 on 11/21/24 | 58.39 on 11/19/24 | ||
| High | 125.14 on 11/21/24 | 20.14 on 11/19/24 | 59.84 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +7.29% since 10/21/24 | -9.37% since 10/21/24 | -0.63% since 10/21/24 | ||
| Low | 113.88 on 10/25/24 | 18.03 on 11/21/24 | 58.29 on 11/05/24 | ||
| High | 131.26 on 10/30/24 | 22.90 on 10/28/24 | 60.32 on 10/22/24 | ||
| 3-Month | |||||
| %Chg | -17.11% since 08/21/24 | +39.28% since 08/21/24 | +0.66% since 08/21/24 | ||
| Low | 110.95 on 10/03/24 | 11.76 on 09/05/24 | 58.29 on 11/05/24 | ||
| High | 154.87 on 08/23/24 | 33.89 on 09/16/24 | 61.20 on 08/30/24 | ||
| 6-Month | |||||
| %Chg | -11.01% since 05/21/24 | +323.23% since 05/21/24 | +8.81% since 05/21/24 | ||
| Low | 110.95 on 10/03/24 | 2.10 on 05/28/24 | 53.51 on 05/29/24 | ||
| High | 157.98 on 08/01/24 | 33.89 on 09/16/24 | 61.20 on 08/30/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,482,742 | 13,731,282 | 10,709,208 | ||
| Shares Outstanding, K | 101,247 | 737,448 | 181,512 | ||
| Annual Sales | 1,887,100,000 | 0 | 4,381,000,000 | ||
| Annual Net Income | 249,700,000 | -614,930,000 | -1,043,000,000 | ||
| Last Quarter Sales | 622,100,000 | 0 | 1,023,000,000 | ||
| Last Quarter Net Income | 129,800,000 | -56,250,000 | -129,000,000 | ||
| 60-Month Beta | 0.35 | -0.92 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.24 on 10/30/24 | -0.08 on 10/30/24 | -0.13 on 11/05/24 | ||
| Latest Earnings Date | 10/30/24 | 10/30/24 | 11/20/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 31.94 | 0.00 | 0.00 | ||